When: Thursday, September 20, 6:00pm-9:00pm.
Where: Boston Children’s Hospital, Auditorium A/B, 1 Autumn Street, Boston, MA 02115 (See below for detailed directions).
Price: Event is open to the postdoctoral scholars.
Registration Link: Event pre-registration is required.
SHOW is an ongoing seminar and networking series that highlights cutting edge, translational, life science research and development. This season of SHOW is focused on where and how today’s young scientists and clinicians are changing the face of life science innovation. You will hear from and meet with scientists and clinicians from all aspects of the life science space regarding how they apply their expertise and experience toward advancing research, commercialization, and healthcare.
For September” SHOW our panelist will share a little about their current position and responsibilities as well as talk about their career journey and their transition form their postdoc to their first position outside of academics.
This special SHOW For National Postdoc Appreciation Week Event will focus on PHD careers outside of Academics.
Please join us for an amazing evening of the science entrepreneurship and networking. Light food and refreshments will be provided
Iya Shestopaloc PhD
lya currently leads the cell analytics group within cellular process development at bluebird bio. His group’s research focuses on development of cell-based phenotyping and functional assays for hematopoietic stem/progenitor and CAR-T products. Prior to joining bluebird bio in 2014, Dr. Shestopalov was a postdoctoral fellow with Len Zon at Boston Children’s Hospital and Harvard University working with zebrafish hematopoietic stem cells. Dr. Shestopalov received his PhD in 2010 from the Chemical Biology program at Stanford University and a BSci in Biological Chemistry from University of Chicago in 2004.
Susan Clugston PhD
Susan currently is a Principal Scientist at Goldfinch Bio. Before joining Goldfinch Bio, Susan was a Principal Scientist at Encanta Pharmaceuticals, a Senior Scientist at Cubist Pharmaceuticals, and a Principal Scientist at Pfizer, Research Technology Center. before moving to industry Susan completed a postdoc at Boston Children’s Hospital/Harvard Medical School in the laboratory of Dr. Christopher Walsh. Susan received her PhD in Chemistry/Biochemistry from the University of Waterloo.
Julie (Szu Yu) Liao PhD
Julie is currently a Scientist II at Versatope Therapeutics which she joined in May of this year. Before joining Versatope, Julie was a postdoc in the laboratory of Dr. Paula Watnick at Boston Children’s Hospital and Havard Medical School. JulierecievedherPHD in Cellular and Molecular Biology from Binghamton University in 2009.
Shuji Sato, PhD
Shuji is currently a Principal Scientist, Endogenous Antibody Discovery, BioMedicine Design at Pfizer Inc. Before joining Biomedicine Design, Shuji was Associate Director of Antibody Technologies at Bluefin Biomedicine, Associate Director of Antibody Technologies and Group Leader of Therapeutic Antibody Development at Cell Signaling Technologies. Before going to industry Shuji completed a postdoc at the New England Primate Center/Harvard Medical School in the laboratory of Dr. Welkin Johnson. Shuji received his PhD in Molecular Microbiology from Tufts University in 2004.
Bryan MacDonald PhD
Bryan is currently a Project Team Leader, Research Scientist II at the Broad Institute. Before joining the Broad Bryan was a postdoc in the laboratory of Dr. Xi He at Boston Children’s Hospital where he worked on the Wnt signaling pathway. Dr. MacDonald received his PhD in Human/Medical Genetics from the University of Michigan in 2004.
Please note for this event the additional location details below: